T1	Participants 102 163	healthy women and in women with primary Raynaud's phenomenon.
T2	Participants 277 290	healthy women
T3	Participants 298 332	patients with Raynaud's phenomenon
T4	Participants 686 758	17 healthy normotensive women and in 12 women with Raynaud's phenomenon.
